Krystal Biotech (KRYS) Non Operating Income (2017 - 2019)

Krystal Biotech has disclosed Non Operating Income across 3 years of filings, most recently posting $542000.0 for Q2 2019.

• Non Operating Income for Q2 2019 came in at $542000.0, up 213.29% year-over-year; the trailing twelve-month figure through Jun 2019 was $1.5 million (up 154.59% YoY), and the FY2017 annual result was -$3.1 million, down 44871.43% from the prior year.
• Non Operating Income came in at $542000.0 for Q2 2019 at Krystal Biotech, down from $583000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $583000.0 in Q1 2019 to a low of -$3.2 million in Q3 2017.
• The 3-year median for Non Operating Income is $127000.0 (2018), against an average of -$167333.3.
• Peak annual rise in Non Operating Income reached 537.93% in 2018, while the deepest fall reached 106.82% in 2018.
• Krystal Biotech's Non Operating Income stood at $105000.0 in 2017, then surged by 106.67% to $217000.0 in 2018, then jumped by 149.77% to $542000.0 in 2019.
• The last three Non Operating Income figures came in at $542000.0 (Q2 2019), $583000.0 (Q1 2019), and $217000.0 (Q3 2018), per Business Quant data.